Tai Sandi See
Chief Development Officer, Lexeo Therapeutics, Inc.
Companies
- Lexeo Therapeutics, Inc.Chief Development Officer Feb 6, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexeo Therapeutics, Inc. LXEO65,476 shares2$176.8K at $2.70Nov 18, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 18, 2025Sold 386 shares at $9.27 of Lexeo Therapeutics, Inc.2
- Oct 17, 2025Sold 44 shares at $9.56 of Lexeo Therapeutics, Inc.3
- Oct 17, 2025Sold 3,844 shares at $8.94 of Lexeo Therapeutics, Inc.3
- Oct 15, 2025Granted 10,890 shares of Lexeo Therapeutics, Inc.3
- Aug 18, 2025Sold 382 shares at $4.67 of Lexeo Therapeutics, Inc.4
- May 16, 2025Sold 367 shares at $2.77 of Lexeo Therapeutics, Inc.5
- Mar 14, 2025Granted 5,720 shares at $2.61 of Lexeo Therapeutics, Inc.6
- Feb 19, 2025Sold 1,486 shares at $4.41 of Lexeo Therapeutics, Inc.7
- Jan 7, 2025Granted 38,750 shares of Lexeo Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Oct 17, 2025
- 4SEC EDGARForm 4 filed Aug 20, 2025
- 5SEC EDGARForm 4 filed May 20, 2025
- 6SEC EDGARForm 4 filed Apr 9, 2025
- 7SEC EDGARForm 4 filed Feb 21, 2025
- 8SEC EDGARForm 4 filed Jan 10, 2025